Daiichi Sankyo Korea
Daiichi Sankyo is a global pharmaceutical company with corporate origins in Japan. We provide innovative products and services in more than 20 countries around the world. With more than 100 years of scientific expertise, our company draws upon a rich legacy of innovation and a robust pipeline of promising new medicines to help patients. We share a passion for innovation, as well as compassion for the patients around the world who are in need of our medicines.
Training Course
Optimal Antithrombotic Therapy 1
Organized by CVRF and Supported by Educational Grant from Daiichi Sankyo Korea
Wednesday, April 21 ~ Saturday, April 24
Edoxaban Update: True or False on Edoxaban Trainer: So-Ryoung Lee |
Optimal Antithrombotic Therapy 2
Organized by CVRF and Supported by Educational Grant from Daiichi Sankyo Korea
Wednesday, April 21 ~ Saturday, April 24
Optimal De-Escalation Strategy of Antiplatelet Therapy for ACS-PCI Trainer: Jeehoon Kang |